Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C
- PMID: 21859997
- PMCID: PMC4874144
- DOI: 10.1200/JCO.2011.36.2335
Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C
Abstract
Purpose: Both hepatitis B (HBV) and C viruses (HCV) are causes of hepatocellular carcinoma (HCC), but lifetime risk and sex difference remain unclear. This study aimed to assess the lifetime risk and sex difference of HCC among patients with chronic HBV and/or HCV.
Methods: A prospective cohort of 23,820 residents of Taiwan age 30 to 65 years were enrolled from 1991 to 1992, with 477 instances of HCC occurring subsequently. Serum samples collected at enrollment were tested for seromarkers and viral load of HBV and HCV. Newly developed HCC was ascertained through computerized data linkage with national cancer registry and death certification systems.
Results: The cumulative lifetime (age 30 to 75 years) incidences of HCC for men and women positive for both HBV surface antigen (HBsAg) and antibodies against HCV (anti-HCV) were 38.35% and 27.40%; for those positive for HBsAg only, 27.38% and 7.99%; for those positive for anti-HCV only, 23.73% and 16.71%; and for those positive for neither, 1.55% and 1.03%, respectively. There was a significant male predominance in incidence of HCC for chronic HBV carriers but not for chronic carriers of HCV or both. Multivariate adjusted hazard ratio of developing HCC decreased with age in HBsAg-seropositive men but increased with age in anti-HCV-seropositive women. Among dual-infected participants, there was an inverse association between HBV and HCV viral load. Risk of HCC increased significantly with increasing viral load of HBV and HCV.
Conclusion: There exists a suppressive effect of HCV on HBV viral load. Individual and combined effects of the two viruses on HCC vary with sex and age.
Conflict of interest statement
Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.
Figures
Similar articles
-
Natural history of chronic hepatitis B REVEALed.J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x. J Gastroenterol Hepatol. 2011. PMID: 21323729 Review.
-
Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma.Int J Cancer. 2014 Sep 1;135(5):1119-26. doi: 10.1002/ijc.28753. Epub 2014 Feb 14. Int J Cancer. 2014. PMID: 24482200
-
Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.Clin Gastroenterol Hepatol. 2016 Mar;14(3):461-468.e2. doi: 10.1016/j.cgh.2015.10.033. Epub 2015 Nov 18. Clin Gastroenterol Hepatol. 2016. PMID: 26598229
-
Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.Hepatology. 2013 Aug;58(2):546-54. doi: 10.1002/hep.26385. Hepatology. 2013. PMID: 23504622
-
What can we learn from hepatitis B virus clinical cohorts?Liver Int. 2015 Jan;35 Suppl 1:91-9. doi: 10.1111/liv.12716. Liver Int. 2015. PMID: 25529093 Review.
Cited by
-
Hepatocellular carcinoma risk scores: ready to use in 2015?Hepat Oncol. 2015 Jan;2(1):1-4. doi: 10.2217/hep.14.32. Epub 2015 Jan 12. Hepat Oncol. 2015. PMID: 30190979 Free PMC article. No abstract available.
-
Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.Front Med. 2014 Jun;8(2):217-26. doi: 10.1007/s11684-014-0326-2. Epub 2014 Apr 21. Front Med. 2014. PMID: 24748463
-
Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular Carcinoma.Cancers (Basel). 2021 Aug 30;13(17):4387. doi: 10.3390/cancers13174387. Cancers (Basel). 2021. PMID: 34503196 Free PMC article. Review.
-
Mediation effect of hepatitis B and C on mortality.Eur J Epidemiol. 2016 Jun;31(6):625-33. doi: 10.1007/s10654-016-0118-x. Epub 2016 Jan 20. Eur J Epidemiol. 2016. PMID: 26792787
-
Hepatitis C Virus and Hepatitis B Virus Co-Infection.Viruses. 2020 Jul 10;12(7):741. doi: 10.3390/v12070741. Viruses. 2020. PMID: 32664198 Free PMC article. Review.
References
-
- Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345:41–52. - PubMed
-
- Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108. - PubMed
-
- Chen CJ, Wang LY, Yu MW. Epidemiology of hepatitis B virus infection in the Asia-Pacific region. J Gastroenterol Hepatol. 2000;15(suppl):E3–E6. - PubMed
-
- Hsu HY, Chang MH, Chen DS, et al. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: A study just before mass hepatitis B vaccination program in Taiwan. J Med Virol. 1986;18:301–307. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources